Nvidia News Digest

Nvidia: 9.3% Stake in Nebius and SIGGRAPH Innovations Drive the Week

A capital stake in neocloud firm Nebius, DLSS 5 and Cosmos AI at SIGGRAPH, and new competitive pressure from AMD's Helios server are shaping the latest Nvidia coverage.

Nvidia: 9,3-Prozent-Beteiligung an Nebius und SIGGRAPH-Neuheiten treiben die Woche
KI-generiert (gpt-image-2)

Nvidia has disclosed a 9.3% stake in neocloud computing firm Nebius, while also unveiling new AI graphics technologies—DLSS 5 and the Cosmos platform—at SIGGRAPH 2026. Both developments come in a week in which Nvidia also faces growing competitive pressure from AMD's new Helios rack server.

  • Nvidia holds a 9.3% stake in neocloud firm Nebius, according to the disclosure, sending NBIS shares sharply higher.
  • At SIGGRAPH 2026, Nvidia presented DLSS 5 along with an expanded push of its Cosmos AI platform for agentic and physical AI.
  • AMD's new Helios rack server is increasing pressure on Nvidia's position in the server business.
  • A report states that a first pharmaceutical company is deploying Nvidia's Vera Rubin to cut drug development timelines by up to 50 percent.
  • A U.S. congressman (Dan Newhouse) has sold NVDA shares, according to MarketBeat.

Why is Nebius stock rising after Nvidia's stake disclosure?

After Nvidia disclosed a stake of over 9% in Nebius, NBIS shares jumped sharply in after-hours trading, according to Yahoo Finance. Analysts see further upside for the neocloud firm, the report notes, as the capital stake is viewed as a strategic signal of Nvidia's commitment to the cloud infrastructure business.

What did Nvidia showcase at SIGGRAPH 2026?

According to Nvidia's own blog, the company presented advances in graphics and simulation at SIGGRAPH 2026 built around agentic and physical AI. In parallel, MarketBeat reported on the unveiling of DLSS 5 as well as an expanded Cosmos AI push during the keynote.

What competition is Nvidia facing in the server business?

AMD has launched a new product, the Helios rack server, which is putting fresh pressure on Nvidia's position in the rack server segment, according to Yahoo Finance Singapore.

How is Nvidia's Vera Rubin being used in the pharmaceutical industry?

A report from Moomoo describes a first pharmaceutical company deploying Nvidia's Vera Rubin technology to shorten drug development timelines by up to 50 percent.

Beyond the AI and stake news, there are also more critical signals: a report from Moomoo describes Nvidia's multi-billion-dollar investments in so-called dark fiber infrastructure as an additional strategic advantage alongside its chip business. Meanwhile, MarketBeat reported that U.S. congressman Dan Newhouse sold shares in Nvidia—a transaction documented as part of routine insider filings.

Taken together, this paints a picture of Nvidia expanding its AI and infrastructure strategy through capital stakes, new software generations, and pharmaceutical partnerships, even as competition in the server and graphics space intensifies from AMD and other providers.

Sources

  1. Nvidia discloses 9.3% stake in neocloud computing firm Nebius · 2026-07-21
  2. NBIS Stock Jumps Overnight As Nvidia Reveals Over 9% Stake, Analyst Sees More Upside · 2026-07-21
  3. At SIGGRAPH, NVIDIA Advances Graphics and Simulation With Agentic and Physical AI · 2026-07-21
  4. NVIDIA Unveils DLSS 5 and Cosmos AI Push at SIGGRAPH Keynote · 2026-07-21
  5. Nvidia (NVDA) Faces Fresh Rack Server Pressure As AMD Launches Helios · 2026-07-21
  6. The first pharmaceutical company to deploy NVIDIA's Vera Rubin has arrived! Drug development timelines could be shortened by 50%. · 2026-07-21
  7. NVIDIA's "Underground" Battle: Why Is the Ten-Billion-Dollar Dark Fiber a Deeper Moat Than Chips? · 2026-07-21
  8. Rep. Dan Newhouse Sells Off Shares of NVIDIA Corporation (NASDAQ:NVDA) · 2026-07-21

Last updated:

Related stories